Hongli (Catherine) Wu public CV

Hongli (Catherine) Wu, PhD

UNT System College of Pharmacy
Associate Professor, North Texas Eye Research Institute
Associate Professor, Pharmaceutical Sciences

EmailHongli.Wu@unthsc.edu

Source: Scopus
Calculated based on no. of publications stored in Pure and citations from Scopus

Research output per year

If you made any changes in Pure these will be visible here soon.

Personal profile

Area of Expertise

Areas of research and interests include:
1) examining how retinal redox imbalance leads to age-related macular degeneration (AMD) pathogenesis;
2) characterizing glutaredoxin 2 (Grx2) knockout mice as a new animal model for AMD;
3) identifying/screening Grx2 inducers from natural products for AMD treatment.

Education/Academic qualification

PhD in Pharmacology, Peking University

BS in Pharmacy, Xinjiang Medical University

MS in Pharmacy, Xinjiang Medical University

Fingerprint

Dive into the research topics where Hongli (Catherine) Wu is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

Network

Recent external collaboration on country level. Dive into details by clicking on the dots.

12 Finished

Evaluate NACA and diNACA in Cone Cells +/- Oxidative Stress
Wu, H. (.
Nacuity Pharmaceuticals, Inc.
7/10/19 → 6/10/20
Project: Research
Evaluate NACA and diNACA in Preventing Oxidative Stress-Induced Cataract Formation: Ex Vivo Study
Wu, H. (.
Nacuity Pharmaceuticals, Inc.
7/10/19 → 6/10/20
Project: Research
Goal: Using ATP Level as a Marker for Laser Setting Optimization
Wu, H. (.
Lensar, Inc.
1/07/19 → 30/06/20
Project: Research
Evaluation of NAC, NACA and diNACA in Cultured RPE Cells and in Cultured Corneal Endothelial Cells (CECs) +/- Oxidative Stress
Clark, A. & Wu, H. (.
Nacuity Pharmaceuticals, Inc.
18/02/19 → 4/06/20
Project: Research
To evaluate the oxidative efficacy of L2 and L4 compounds in PC12 cells
Wu, H. (.
Texas Christian University
22/01/19 → 21/01/20
Project: Research

751 Citations
13 h-Index
18 Article
2 Review article

Enhancement of the Antioxidant Activity and Neurotherapeutic Features through Pyridol Addition to Tetraazamacrocyclic Molecules
Johnston, H. M., Pota, K., Barnett, M. M., Kinsinger, O., Braden, P., Schwartz, T. M., Hoffer, E., Sadagopan, N., Nguyen, N., Yu, Y., Gonzalez, P., Tircsó, G., Wu, H., Akkaraju, G., Chumley, M. J. & Green, K. N., 16 Dec 2019, In: Inorganic Chemistry. 58, 24, p. 16771-16784 14 p.
Research output: Contribution to journal › Article › peer-review
3 Scopus citations
Cataract preventive role of isolated phytoconstituents: Findings from a decade of research
Lim, V., Schneider, E., Wu, H. & Pang, I. H., Nov 2018, In: Nutrients. 10, 11, 1580.
Research output: Contribution to journal › Review article › peer-review
5 Scopus citations
Involvement of Nrf2 in ocular diseases
Batliwala, S., Xavier, C., Liu, Y., Wu, H. & Pang, I. H., 2017, In: Oxidative Medicine and Cellular Longevity. 2017, 1703810.
Research output: Contribution to journal › Review article › peer-review
27 Scopus citations
Salvianolic acid B (Sal B) protects retinal pigment epithelial cells from oxidative stress-induced cell death by activating glutaredoxin 1 (Grx1)
Liu, X., Xavier, C., Jann, J. & Wu, H., 3 Nov 2016, In: International journal of molecular sciences. 17, 11, 1835.
Research output: Contribution to journal › Article › peer-review
19 Scopus citations
The novel triterpenoid RTA 408 protects human retinal pigment epithelial cells against H₂O₂-induced cell injury via NF-E2-related factor 2 (Nrf2) activation
Liu, X., Ward, K., Xavier, C., Jann, J., Clark, A. F., Pang, I. H. & Wu, H., 1 Aug 2016, In: Redox Biology. 8, p. 98-109 12 p.
Research output: Contribution to journal › Article › peer-review
31 Scopus citations